Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Forecast Through 2030 Featuring Industry Drivers And Opportunities
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Growth In Market Size Of The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market During 2026–2030?
The artificial intelligence (AI)-powered clinical trial site feasibility market size has experienced substantial growth in recent years. It is forecast to expand from $1.53 billion in 2025 to $1.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.6%. This historical market expansion can be ascribed to increasing complexity of clinical trial designs, rising cost pressures on drug development timelines, growing reliance on data-driven trial planning, expansion of global multi-site clinical trials, and early adoption of predictive analytics in trial feasibility.
The artificial intelligence (AI)-powered clinical trial site feasibility market size is projected to experience substantial growth in the coming years. This sector is expected to reach $4.38 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 23.3%.
This growth during the forecast period is primarily driven by the increasing adoption of decentralized clinical trials, a rising need for faster site activation, the expanded utilization of real-world evidence in feasibility decisions, the proliferation of AI-enabled trial planning platforms, and a greater emphasis on mitigating trial risks. Concurrently, major trends anticipated include the growing embrace of AI-driven site selection models, a surge in the use of predictive patient recruitment analytics, deeper integration of real-world data into feasibility assessments, the expansion of cloud-based feasibility platforms, and an enhanced focus on forecasting trial performance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp
What Are The Main Drivers Accelerating The Growth Of The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
The anticipated expansion of clinical trials is projected to fuel the advancement of the artificial intelligence (AI)-powered clinical trial site feasibility market. Clinical trials encompass global research investigations aimed at evaluating the safety and effectiveness of novel medical treatments, pharmaceuticals, and devices. This increase in clinical trials primarily stems from heightened investments in biomedical research and development, as both public and private entities acknowledge the vital necessity of groundbreaking treatments to confront evolving healthcare issues. The proliferation of clinical trials consequently boosts the demand for AI-powered site feasibility tools, given that research organizations require effective systems to pinpoint ideal locations, evaluate site competencies, and forecast participant enrollment success for their studies. Illustratively, in April 2025, data from the Multidisciplinary Digital Publishing Institute, a Swiss publisher of open-access scientific journals, indicated that the total number of clinical trials available on the clinicaltrials.gov webpage reached 404,637. Consequently, the expansion of clinical trials is a key driver for the advancement of the artificial intelligence (AI)-powered clinical trial site feasibility market.
How Is The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Distributed Across Key Segments?
The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users
Subsegments:
1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software
2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services
Which Trends Are Affecting The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Framework?
Leading companies operating in the artificial intelligence-powered clinical trial site feasibility market are focusing on developing advanced solutions, such as an artificial intelligence-powered feasibility and recruitment platform, to optimize site selection and improve overall operational efficiency in clinical trials. This specific platform functions as a software tool that leverages AI and machine learning to assess trial protocols and site data, aiming to identify optimal clinical sites and enhance patient recruitment by efficiently matching eligible participants to accelerate trial timelines and boost study success. For instance, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, launched ObjectiveScreen. This artificial intelligence-powered feasibility and recruitment platform is designed to optimize clinical trial performance through enhanced patient identification, prequalification, and retention, achieved via real-time integration with electronic health records (EHRs) and the application of AI and machine learning algorithms. The platform empowers clinical trial sites to connect directly with patient data, stratify health risks, and pinpoint the most qualified candidates, ultimately accelerating enrollment and improving trial outcomes.
Which Industry Players Are Present In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI
Access The Complete Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report:
Which Geographic Region Represents The Largest Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Share?
North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28137&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company
Ai Based Clinical Trial Solution Providers Global Market Report 2026
Ai In Clinical Trials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report
Virtual Clinical Trials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
